WASHINGTON--(BUSINESS WIRE)--ADVI Health, a life sciences data and consulting services firm, announced today the addition of two highly respected healthcare executives, Rod Cavin and Scott Howell, to ADVI Health’s Board of Directors.
“Rod and Scott bring an impressive track record in life sciences, particularly within pharmaceutical services. Their strong commercial leadership skills and a background rich in substantial M&A deal-making complement ADVI Health’s Board,” said Marc Samuels, CEO of ADVI Health. “These seasoned individuals serve as pivotal figures guiding us on our journey toward rapid growth and market dominance."
Rod Cavin, Entrepreneur and Health Care Executive
Rod Cavin is a transformative, forward-thinking, dynamic entrepreneur and healthcare executive with a proven track record of building and scaling business for growth through strategic planning, executional excellence, and building teams with strong cultures for success. Rod was CEO of Health Strategies Group for fifteen-plus years, delivering double-digit growth and leading to a successful sale to EVERSANA in 2017, where he remained in a senior leadership role for several years. Rod’s experience spans corporate governance, financial planning and management, organizational design, leadership development, product development, business development, market planning, and business partnership development. His subject matter expertise traverses the life sciences, bio-pharmaceutical and medical device industries in both global and US markets, with expertise in therapeutic areas including oncology, rare disease, cardiology, diabetes, auto immune, and digital therapeutics.
Scott Howell M.D., Academic and Strategic Advisor
Scott Howell M.D. is an accomplished healthcare general manager and strategist with an uncommon breadth of experience across multiple healthcare segments, including medical practice and administration, managed care, pharmaceuticals and biotech, distribution, specialty pharmacy, consulting and HEOR, and molecular diagnostics. Scott has particular expertise in drug pricing, contracting, reimbursement, market access, patient services, and early product planning. His prior roles include strategy and execution at biopharmaceutical manufacturers Novartis, Jazz, Genentech, and GSK; and account management, pharmacy and medical affairs, and drug development at both Cardinal Health and Highmark BCBS. Scott is also a frequent speaker, author, podcast co-host, and guest lecturer at MBA and MPH programs at UC Berkley.
For more information about ADVI Health, please visit www.advi.com.
About ADVI Health
ADVI Health is the strategic consulting partner to the healthcare and life sciences ecosystem. A leading life sciences data and consulting services firm with offices in Austin, Chicago, San Francisco, and Washington, DC, we solve complicated problems in healthcare with data-informed commercialization, market access, and policy expertise. From development and design to strategy and execution we succeed for clients across managed services, medtech, pharma, and precision medicine, with insights, products, and services across the product lifecycle. ADVI’s Strategic Analytics and Value Economics (SAVEs) data capabilities span multiple payers (100% Medicaid FFS, Medicaid health plans, Medicare FFS, and Medicare Advantage) and covers over 200 million lives providing clients with invaluable insights and competitive intelligence.
About Sheridan Capital Partners
Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, bringing strategic resources to accelerate growth, build enduring value, and achieve strong results.
